Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.46M | $0.00 | -$30.62M | -$35.84M | -$5.66 | N/A | -100.00% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $17.70M | $0.00 | -$17.74M | -$18.50M | -$0.48 | N/A | N/A | N/A | N/A | |||
| ACET | ADICET BIO INC | $80.94M | $0.00 | -$105.29M | -$115.01M | -$20.00 | N/A | -100.00% | N/A | N/A | 2026-03-05 | ||
| NRXP | NRX PHARMACEUTICALS INC | $68.84M | $242.00k | -$38.02M | -$38.06M | -$2.36 | N/A | N/A | N/A | N/A | |||
| SKYE | SKYE BIOSCIENCE INC | $35.58M | $0.00 | -$50.55M | -$51.23M | -$1.29 | N/A | N/A | N/A | N/A | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $44.61M | $752.00k | -$51.29M | -$68.21M | -$9.04 | -66.96% | N/A | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $36.49M | $4.02M | -$8.73M | -$13.95M | -$8.50 | -21.70% | -31.91% | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $19.97M | $0.00 | -$14.51M | -$12.70M | -$0.55 | N/A | N/A | N/A | N/A | 2026-02-25 | ||
| OSTX | OS THERAPIES INC | $53.88M | $0.00 | -$18.04M | -$20.26M | -$0.82 | N/A | N/A | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $154.79M | $32.88M | -$101.50M | -$108.91M | -$0.45 | -37.13% | -25.91% | N/A | N/A | 2026-02-25 | ||
| PSTV | PLUS THERAPEUTICS INC | $83.83M | $5.26M | -$16.33M | -$20.58M | -$1.70 | -8.16% | 28.67% | N/A | N/A | |||
| FEMY | FEMASYS INC | $36.55M | $2.06M | -$17.01M | -$19.80M | -$0.72 | 63.53% | N/A | N/A | N/A | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $420.98M | $0.00 | -$227.85M | -$240.91M | -$2.25 | N/A | N/A | N/A | N/A | 2026-03-02 | ||
| CODX | CO-DIAGNOSTICS INC | $12.24M | $507.89k | -$32.14M | -$32.18M | -$29.70 | -93.06% | -59.66% | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $18.61M | $1.07M | -$19.03M | -$18.24M | -$2.13 | N/A | N/A | N/A | N/A | 2026-02-26 | ||
| NAKA | KINDLY MD INC | $206.29M | $1.98M | -$89.61M | -$90.49M | -$1.11 | -31.13% | N/A | N/A | N/A | 2026-02-13 | ||
| VERU | VERU INC | $38.04M | $0.00 | -$22.57M | -$22.73M | -$1.55 | N/A | -100.00% | N/A | N/A | |||
| SLN | SILENCE THERAPEUTICS PLC | $273.68M | $26.10M | -$67.75M | -$66.59M | N/A | 27.31% | N/A | N/A | N/A | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $46.68M | $0.00 | -$32.21M | -$34.88M | -$0.82 | N/A | N/A | N/A | N/A | |||
| IMUX | IMMUNIC INC | $83.00M | $0.00 | -$102.73M | -$103.05M | -$0.83 | N/A | N/A | N/A | N/A | 2026-02-19 | ||
| PALI | PALISADE BIO INC | $300.99M | $0.00 | -$11.10M | -$11.23M | -$2.12 | N/A | -100.00% | N/A | N/A | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $39.81M | $0.00 | -$22.71M | -$22.76M | -$0.46 | N/A | N/A | N/A | N/A | |||
| SNTI | SENTI BIOSCIENCES INC | $30.23M | $0.00 | -$43.38M | -$47.58M | -$3.28 | N/A | N/A | N/A | N/A | |||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.09M | $1.23M | -$7.89M | -$8.47M | -$0.32 | 314.67% | N/A | N/A | N/A | |||
| ONCY | ONCOLYTICS BIOTECH INC | $99.59M | $0.00 | -$25.02M | -$25.19M | -$0.28 | N/A | N/A | N/A | N/A | 2026-03-05 | ||
| AKTX | AKARI THERAPEUTICS PLC | $20.51M | $0.00 | -$16.51M | -$15.77M | $0.00 | N/A | N/A | N/A | N/A | |||
| KRRO | KORRO BIO INC | $79.95M | $7.37M | -$82.74M | -$88.42M | -$9.41 | N/A | -25.32% | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $17.78M | $0.00 | -$29.28M | -$29.28M | -$18.90 | N/A | N/A | N/A | N/A | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $67.15M | $500.00k | -$42.09M | -$41.57M | -$0.30 | -50.00% | N/A | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $73.20M | $190.00k | -$73.96M | -$75.12M | -$0.82 | -19.15% | -53.29% | N/A | N/A | |||
| IFRX | INFLARX NV | $81.30M | $73.07k | -$46.08M | -$46.63M | -$0.70 | -60.51% | N/A | N/A | N/A | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $6.18M | $11.57M | -$10.72M | -$15.86M | -$25.27 | -48.05% | 49.54% | N/A | N/A | |||
| ZSPC | ZSPACE INC | $14.58M | $31.55M | -$20.08M | -$21.79M | -$135.53 | -24.20% | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $42.71M | $34.35M | -$8.52M | -$10.59M | -$0.18 | 15.09% | -1.19% | N/A | N/A | |||
| MSAI | MULTISENSOR AI HOLDINGS INC | $18.34M | $5.56M | -$11.29M | -$12.42M | -$0.25 | -26.96% | N/A | N/A | N/A | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $16.72M | $2.48M | -$11.54M | -$12.16M | -$1.02 | 280.77% | -16.28% | N/A | N/A | |||
| VNRX | VOLITIONRX LTD | $35.12M | $1.47M | -$21.14M | -$22.88M | -$0.23 | 14.48% | 197.53% | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $168.90M | $1.20M | -$21.76M | -$28.32M | -$0.79 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $33.58M | $0.00 | -$21.49M | -$22.06M | -$3.62 | N/A | N/A | N/A | N/A | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.11M | $0.00 | -$65.24M | -$72.84M | -$1.62 | -100.00% | N/A | N/A | N/A | |||
| HUMA | HUMACYTE INC | $224.73M | $1.57M | -$18.88M | -$36.97M | -$0.23 | N/A | N/A | N/A | N/A | |||
| MYO | MYOMO INC | $40.36M | $41.64M | -$9.73M | -$12.02M | -$0.28 | 64.99% | 50.95% | N/A | N/A | |||
| CABA | CABALETTA BIO INC | $206.01M | $0.00 | -$145.48M | -$158.52M | -$2.53 | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $167.68M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| TNYA | TENAYA THERAPEUTICS INC | $133.20M | $0.00 | -$82.99M | -$94.26M | -$0.77 | N/A | N/A | N/A | N/A | |||
| IBRX | IMMUNITYBIO INC | $2.17B | $82.56M | -$203.60M | -$348.62M | -$0.39 | 1,025.95% | 95.11% | N/A | N/A | 2026-03-02 | ||
| BMEA | BIOMEA FUSION INC | $94.04M | $0.00 | -$91.46M | -$95.71M | -$2.38 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.